Security key
G2161P140
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)
CUSIP: G2161P140
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common stock, $0.08 par value
- Total 13F shares
- 10,008
- Total 13F value
- $5,085
- Share change
- -36,507
- SEC-reported price per share
- $0.50
- Number of holders
- 2
- Value change
- -$21,536
- Number of sells
- 4
Report period
Q4 2024
Institutions
2
Top holders
2
SXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
China SXT Pharmaceuticals, Inc. SEC filings
China SXT Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G2161P140
Recent filing periods:
Ownership snapshot
Top reported holders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GSA CAPITAL PARTNERS LLP
Disclosed value leader
GSA CAPITAL PARTNERS LLP
Comparable rows
0/6
Latest evidence
30 Sep 2024
13F
3/4/5
Highest disclosed value: $9,000
6 rows are not safely comparable across share classes.
Quick read
GSA CAPITAL PARTNERS LLP has the largest disclosed position value at $9K.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GSA CAPITAL PARTNERS LLP's linked filing trail.
Disclosed position value
Top 5
GSA CAPITAL PARTNERS LLP
$9K
Baader Bank Aktiengesellschaft
$7.9K
BANK OF MONTREAL /CAN/
$6.4K
UBS Group AG
$6.3K
JPMORGAN CHASE & CO
$274
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
—
class O/S missing
|
$9,000
12,300 shares
|
— | 30 Sep 2024 |
| Baader Bank Aktiengesellschaft |
13F
Company
|
—
class O/S missing
|
$7,927
15,161 shares
|
— | 30 Sep 2024 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
class O/S missing
|
$6,420
10,000 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$6,335
8,678 shares
|
— | 30 Sep 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$274
376 shares
|
— | 30 Sep 2024 |
| Feng Felix Zhou |
3/4/5
Co-CEO and Director, Director
|
—
class O/S missing
|
—
4 shares
|
— | 04 Jul 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
10,008
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
5
Q4 2024 holders
2
Holder diff
-3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend